Cancer Biology: Difference between revisions
Content added Content deleted
No edit summary |
No edit summary |
||
Line 43: | Line 43: | ||
| English |
| English |
||
| Undergraduate |
| Undergraduate |
||
|- |
|- |
||
| The DNA Damage Response as a Target for Anti-Cancer Therapy |
| The DNA Damage Response as a Target for Anti-Cancer Therapy |
||
Line 230: | Line 233: | ||
===Select Recordings=== |
===Select Recordings=== |
||
Line 236: | Line 238: | ||
Chan, Geoffrey. 2012. [http://ocw.tufts.edu/data/38/450392.pdf Hematology Oncology]. Boston, MA: Tufts OpenCourseWare. |
Chan, Geoffrey. 2012. [http://ocw.tufts.edu/data/38/450392.pdf Hematology Oncology]. Boston, MA: Tufts OpenCourseWare. |
||
Esserman, MD, Laura J., Ian M. Thompson, Jr, MD, Brian Reid, MD. 2013. [https://jama.jamanetwork.com/article.aspx?articleid=1722196 Overdiagnosis and Overtreatment in Cancer: An Opportunity for Improvement]. August 28. JAMA. 2013;310(8):797-798. doi:10.1001/jama.2013.108415. JAMA. |
|||
jones_supa. 2012. [http://news.slashdot.org/story/12/03/09/217219/coca-cola-and-pepsi-change-recipe-to-avoid-cancer-warning Coca-Cola and Pepsi Change Recipe To Avoid Cancer Warning]. March 9. news.slashdot.org |
jones_supa. 2012. [http://news.slashdot.org/story/12/03/09/217219/coca-cola-and-pepsi-change-recipe-to-avoid-cancer-warning Coca-Cola and Pepsi Change Recipe To Avoid Cancer Warning]. March 9. news.slashdot.org |
||
Line 294: | Line 298: | ||
===Select Video and Audio=== |
===Select Video and Audio=== |
||
Ferber, Dan. 2013. [http://news.harvard.edu/gazette/story/2013/09/cancer-vaccine-begins-phase-i-clinical-trials/ Cancer vaccine begins Phase I clinical trials: Designed to target skin cancer, implantable vaccine opens door to treating many cancers, inflammatory diseases]. September 6. Cambridge, MA: Harvard Gazette. |
Ferber, Dan. 2013. [http://news.harvard.edu/gazette/story/2013/09/cancer-vaccine-begins-phase-i-clinical-trials/ Cancer vaccine begins Phase I clinical trials: Designed to target skin cancer, implantable vaccine opens door to treating many cancers, inflammatory diseases]. September 6. Cambridge, MA: Harvard Gazette. |
||